NuVasive downgraded by Wells Fargo with a new price target

2/10/23 8:01:18 AM ET

Medical/Dental Instruments

Health Care

Wells Fargo downgraded NuVasive from Overweight to Equal Weight and set a new price target of $57.72

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NUVA

Date	Price Target	Rating	Analyst
2/10/2023	$57.72	Overweight → Equal Weight	Wells Fargo
2/10/2023	$63.00 → $52.00	Buy → Neutral	Citigroup
2/10/2023	$51.00 → $52.50	Buy → Hold	Truist
1/6/2023		Buy → Hold	Needham
10/18/2022	$53.00	Overweight	Barclays
10/12/2022	$45.00	Hold	Jefferies
4/13/2022	$60.00 → $65.00	Buy	Truist
3/28/2022	$58.00	Overweight	Wells Fargo